Clinical Genomics and Sequencing Genomics and Disease Risk Investigation of the impact of genomic variants on response to drug treatment in diverse populations; establishment and implementation of pharmacogenomic-based drug dosing guidelines; and production of evidence-based resources for clinical applications of pharmacogenomics. Rongling Li, M.D., Ph.D., M.P.H. Simona Volpi, Ph.D. Pharmacogenetics, pharmacogenomics, drug gene interactions